HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,252 | +18.0% | 9,038 | +11.4% | 0.07% | -12.9% |
| Q2 2023 | $292,600 | +114.4% | 8,112 | +127.0% | 0.08% | +93.2% |
| Q1 2023 | $136,491 | -39.5% | 3,574 | -9.9% | 0.04% | -41.3% |
| Q4 2022 | $225,665 | +35.1% | 3,966 | -6.2% | 0.08% | -8.5% |
| Q3 2022 | $167,000 | -13.9% | 4,226 | -4.1% | 0.08% | -31.7% |
| Q2 2022 | $194,000 | -41.0% | 4,407 | -46.6% | 0.12% | -27.3% |
| Q1 2022 | $329,000 | -20.7% | 8,256 | -20.0% | 0.16% | -14.5% |
| Q4 2021 | $415,000 | +24.3% | 10,321 | +25.6% | 0.19% | -10.2% |
| Q3 2021 | $334,000 | +18.4% | 8,215 | +32.5% | 0.22% | +20.8% |
| Q2 2021 | $282,000 | – | 6,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |